Oncology CME

Credits: 1.50 CME / MOC
Penn State College of Medicine
Raising the Bar With Innovative Therapy for Bladder Cancer: Insights on Clinical Decision-Making in the New Era of Care
Arjun Balar, MD
March 17, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
The Continuing Wave of Innovation in AML: Getting the Most From the Convergence of Novel Therapy and Allogeneic Transplant
Harry P. Erba, MD, PhD / James M. Foran, MD, FRCPC
March 13, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
Taking the Leap With CAR T: Opportunities for Improving Care and Optimizing Cell Therapy in Hematologic Cancers
Michael R. Bishop, MD
March 12, 2020
Credits: 1.00 CME
The Medical College of Wisconsin
Following the Trail of Evidence in VOD Management: How Modern Risk Assessment, Diagnostic Principles, and Treatment Are Improving Care
Mitchell S. Cairo, MD
March 11, 2020
Credits: 1.00 CME / MOC / CNE / CPE
Penn State College of Medicine
Advancing Bladder Cancer Care With Novel Therapeutics: Where We Are Headed With Immunotherapy, Targeted, and Antibody Options
Arjun Balar, MD
March 10, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Evidence and Practicalities: Checkpoint Inhibition in Gastrointestinal Cancers—Translating Recent Advances in Gastric, Esophageal, and Colorectal Cancers
Manish A. Shah, MD
March 9, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Developing a Therapeutic Game Plan for the Management of Hepatocellular Carcinoma: Expert Insights From the Patient CaseBook
Richard S. Finn, MD
March 6, 2020
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
How I Think, How I Treat—Personal Insights on Current Practices and Evolving Standards of Care in Pancreatic Cancer: Expert Perspectives on Implementing State-of-the-Art Care in the Clinic
Johanna C. Bendell, MD
March 5, 2020
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
Blazing the Therapeutic Management Trail of Biliary Cancers: Get Prepared for a New Era of Molecular- and Mutation-Driven Treatments
Milind Javle, MD
February 25, 2020
Credits: 2.00 CME
Penn State College of Medicine
Realizing the Promise of Novel Therapeutics in NHL: A MasterClass and Tumor Board on Clinical Decision-Making in FL, MCL, and DLBCL
John P. Leonard, MD
January 28, 2020
Credits: 1.00 CNE
Medical Learning Institute, Inc.
Maximizing the Benefits and Minimizing the Risks of Cancer Immunotherapies in Everyday Oncology Practice: Need-to-Know Information and Practical Guidance for Oncology Nurses
Marianne Davies, DNP, ACNP, AOCNP
January 27, 2020
Medical Learning Institute, Inc.
The Expanding Playbook of Hepatocellular Carcinoma: Examining Scientific Data and Evidence With Your Multidisciplinary Team
Richard S. Finn, MD
January 13, 2020
Medical Learning Institute, Inc.
How I Think, How I Treat: Understanding and Working With New Immunotherapeutic and Targeted Management Models in Advanced RCC
Toni K. Choueiri, MD
December 31, 2019
Penn State College of Medicine
Expanding Options for Prophylaxis and Treatment of Acute and Chronic GVHD: Mapping the Path to Better Patient Outcomes in Post-Transplant Care
Miguel-Angel Perales, MD
December 31, 2019
Medical Learning Institute, Inc.
How I Think, How I Treat: BTK Inhibitors as a Clinical Strategy in CLL, MCL, and Beyond—Therapeutic Selection, Sequencing, and Next Steps
Andre H. Goy, MD
December 30, 2019
Medical Learning Institute, Inc.
On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum
Peter Schmid, FRCP, MD, PhD
December 30, 2019
Medical Learning Institute, Inc.
Enhancing Standards of Care for Patients With Biliary Tract Cancers: A Graphical Guide to Integrating a New Lineup of Targeted Therapies Into Practice
Milind Javle, MD
December 27, 2019
Medical Learning Institute, Inc.
MasterClass & Tumor Board⁠—Joining Forces in Hepatocellular Carcinoma: Enhancing Multidisciplinary Care in an Era of New Therapeutic Solutions
Amit Singal, MD, MS
December 24, 2019
Medical Learning Institute, Inc.
Putting Tenosynovial Giant Cell Tumor on Notice: Multidisciplinary Treatment and Implications of New Science
Robin L. Jones, MD
December 19, 2019
Medical Learning Institute, Inc.
Best Practices for Recognizing & Managing Immune-Related Adverse Events in the Emergency Department: Become Aware, Stay Alert, Change Your Practice, & Keep Patients With Cancer Safe
Evan J. Lipson, MD / Andrew Stolbach, MD, MPH
November 27, 2019
Penn State College of Medicine
Advances in Precision Care in Solid Tumor Oncology: Defining the Role of PARP Inhibitors
Robert Coleman, MD
November 8, 2019
Medical Learning Institute, Inc.
Composing Personalized HCC Treatment Strategies: Insights on Harmonizing Patient Care With a Multidisciplinary Ensemble
Ghassan Abou-Alfa, MD, MBA
November 4, 2019
Medical Learning Institute, Inc.
Challenges, Controversies, and Opportunities in the Management of EGFR-Mutant Lung Cancer With Central Nervous System Metastases: Working Together to Improve Patient Outcomes
Kathryn Beal, MD / Sandip Patel, MD
November 4, 2019
Medical Learning Institute, Inc.
Identification, Triage, and Management of Immune-Related Adverse Effects in Patients With Cancer Presenting to the Emergency Department: Practical Guidance for Emergency Nurses
Sorayah Bourenane, MSN, RN, CNL / Marianne Davies, DNP, ACNP, AOCNP
October 29, 2019
Penn State College of Medicine
Driving Change in Multiple Myeloma: Updates on Novel Agent Classes and Next-Generation Therapeutics
Robert Z. Orlowski, MD, PhD
August 8, 2019
Medical Learning Institute, Inc.
Expanding Treatment Choices in Mesothelioma: Exploring the Promise of Tumor Treating Fields and Novel Systemic Approaches to Optimize Patient Outcomes
Charles B. Simone, MD, FACRO
July 29, 2019
Medical Learning Institute, Inc.
Beyond the Basics of Immuno-Oncology: Navigating Clinical Challenges to Maximize the Benefits and Minimize the Risks of Cancer Immunotherapies
Evan J. Lipson, MD
June 26, 2019
Medical Learning Institute, Inc.
Expanding Options and Difficult Choices in the Initial Treatment of Advanced NSCLC: How to Personalize Treatment Decisions in the Era of Immuno-Oncology and Combinations
Mark A. Socinski, MD
March 27, 2019
Medical Learning Institute, Inc.
Urgent Care of Patients Receiving Cancer Immunotherapy: Recognition and Management of Immune-Mediated Adverse Reactions in the ED
Evan J. Lipson, MD
February 22, 2019

Pages